Related Experiment Video
Updated: Aug 5, 2026

07:29
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Mapping the Bioenergetic Landscape of Oral Cancer Stem Cells: A Systematic Review
Rodrigo Elísio de Sá1, Rebeca Barbosa da Rocha1, Benedito Dos Santos Alves1
1Laboratório de Cultura de Células Do Delta (LCCDelta), Universidade Federal Delta do Parnaíba, UFDPar, Parnaíba, PI, Brazil.
Oral Diseases
|August 4, 2026
Summary
Mitochondria drive oral squamous cell carcinoma (OSSC) stem cell survival and drug resistance. Targeting mitochondrial pathways offers a promising strategy to overcome OSSC treatment resistance.
Area of Science:
- Oncology
- Cell Biology
- Mitochondrial Biology
Background:
- Oral squamous cell carcinoma (OSSC) exhibits high lethality, often linked to drug resistance mediated by cancer stem cells (CSCs).
- Mitochondrial reprogramming is crucial for CSC survival, self-renewal, and redox control in OSSC.
Purpose of the Study:
- To systematically review mitochondrial mechanisms sustaining CSCs in OSSC.
- To evaluate the therapeutic relevance of these mitochondrial pathways in OSSC.
Main Methods:
- Systematic literature search following PRISMA guidelines.
- Data extraction on mitochondrial biogenesis, dynamics, mitophagy, and redox regulation in oral CSCs.
- Analysis of molecular pathways, functional roles, and pharmacological targeting.
Main Results:
- Mitochondrial remodeling via biogenesis (PGC-1α/ERRα), fission (DRP1), mitophagy (BNIP3/PINK1), and antioxidant signaling (NRF2) supports OSSC CSCs.
- These pathways enhance metabolic flexibility, drug tolerance, and activate stemness regulators (EGFR/JNK/SOX2, YAP/CCN1, SIRT1/PGC-1α).
- Targeting agents (DRP1 inhibitors, SIRT1/ERRα antagonists, melatonin, verteporfin) show potential to sensitize CSCs to therapy.
Conclusions:
- Mitochondria are central regulators of OSSC CSC biology and viable therapeutic targets.
- Integrating mitochondrial dynamics, metabolism, and redox control is key to overcoming OSSC resistance.
- Further research is needed to translate these findings into effective OSSC therapies.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
